Panic disorder and the heart: A cardiology perspective

Journal of Psychosomatic Research

Volumn 48, Issue 4-5, 2000, Pages 393-403

  Jeejeebhoy, Farida M ^a   Dorian, Paul ^a   Newman, David M ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Clinical cardiology; Palpitations; Panic disorder; Perspective

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE; CLONAZEPAM; FLUOXETINE; IMIPRAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

BEHAVIOR THERAPY; CARDIOLOGY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COGNITIVE THERAPY; CORONARY ARTERY DISEASE; DIFFERENTIAL DIAGNOSIS; HEART; HEART PALPITATION; HUMAN; MORBIDITY; MORTALITY; PANIC; PRACTICE GUIDELINE; REVIEW; SYNDROME X;

CARDIOVASCULAR DISEASES; DIAGNOSIS, DIFFERENTIAL; HUMANS; PANIC DISORDER; REFERRAL AND CONSULTATION;

EID: 0033933021     PISSN: 00223999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3999(99)00103-8     Document Type: Review

References (131)

1. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Association 1994.
2. Ballenger J. Unrecognized prevalence of panic disorder in primary care, internal medicine and cardiology. Am J Cardiol. 60:1987;39J-47J.
3. Jama G., Weissman M., Ouellette R.et al. Panic attacks in the community. JAMA. 265:1991;742-746.
4. Kessler R.C., McGonagle K.A., Zhao S.et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. results from the National Comorbidity Survey Arch Gen Psychiatry. 51:1994;8-19.
5. Beitman B.D., Mukerji V., Lamberti J.W.et al. Panic disorder in patients with chest pain and angiographically normal coronary arteries. Am J Cardiol. 63:1989;1399-1403.
6. Beitman B.D., Basha I., Flaker G. Atypical or nonanginal chest pain. Panic disorder or coronary artery disease? Arch Intern Med. 147:1987;1548-1552.
7. Carter C., Maddock R., Zoglio M., Lutrin C., Jella S., Amsterdam E. Panic disorder and chest pain. a study of cardiac stress scintigraphy patients Am J Cardiol. 74:1994;296-298.
8. Fleet R.P., Dupuis G., Marchand A., Burelle D., Arsenault A., Beitman B.D. Panic disorder in emergency department chest pain patients. prevalence, comorbidity, suicidal ideation and physical recognition Am J Med. 101:1996;371-380.
9. Yingling K.W., Wulsin L.R., Arnold L.M.et al. Estimated prevalences of panic disorder and depression among consecutive patients seen in an emergency department with acute chest pain. J Gen Intern Med. 16:1993;319-324.
10. Barsky A.J., Delamater B.A., Clancy S.A.et al. Somatized psychiatric disorder presenting as palpitations. Arch Intern Med. 156:1996;1102-1108.
11. Carter C., Maddock R., Amsterdam E., McCormick S., Waters C., Billette J. Panic disorder and chest pain in the coronary care unit. Psychosomatics. 33:1992;302-309.
12. Chigon J., Lepine J., Ades J. Panic disorder in cardiac out-patients. Am J Psychiatry. 150:1993;780-785.
13. Morris A., Baker B., Devins G.M., Shapiro C.M. Prevalence of panic disorder in cardiac outpatients. Can J Psychiatry. 42:1997;185-190.
14. Kaplan S., Grebb J. Panic disorder and agoraphobia. Kaplan H.I., Sadock B.J., Grebb J.A. Synopsis of psychiatry. 7th ed:1994;582-592 Williams & Wilkins, Baltimore, Maryland.
15. Regier D., Boyd J., Burke J.et al. One month procedure of mental disorder in the US. Arch Gen Psychiatry. 45:1988;977-986.
16. Beitman B.D., Kushner M., Grossberg G.T. Late onset panic disorder. evidence from a study of patients with chest pain and normal cardiac evaluations Int J Psychiatry Med. 21:1991;29-35.
17. Kemp H.G. Left ventricular function in patients with the anginal syndrome and normal coronary arteriograms. Am J Cardiol. 32:1973;375-376.
18. Proudfit W.L., Shirley E.K., Sones F.M. Selective cine coronary arteriography. Correlation with clinical findings in 1,000 patients. Circulation. 33:1966;901.
19. Katon W., Hall M.L., Russo J.et al. Chest pain. relationship of psychiatric illness to coronary arteriographic results Am J Med. 84:1988;1-9.
20. Wulsin L.R., Hillard J.R., Geier P., Hissa D., Rouan G.W. Screening emergency room patients with atypical chest pain for depression and panic disorder. Int J Psychiatry Med. 18:1988;315-323.
21. Kushner M.G., Beitman B.D., Beck N.C. Factors predictive of panic disorder in cardiology patients with chest pain and no evidence of coronary artery disease. J Psychosom Res. 33:1989;207-215.
22. Carter C.S., Servan-Schreiber D., Perlstein W.M. Anxiety disorders and the syndrome of chest pain with normal coronary arteries. prevalence and pathophysiology J Clin Psychiatry. 58:1997;70-73.
23. Lantinga L.J., Spraikin R.P., McCroskery J.H., Baker M.T., Wamer R.A., Hill N.E. One-year psychosocial follow-up of patients with chest pain and angiographically normal coronary arteries. Am J Cardiol. 62:1988;209-213.
24. Beitman B.D., Kushner M.G., Basha I., Lamberti J.W., Mukerji V., Bartels K. Follow-up status of patients with angiographically normal coronary arteries and panic disorder. JAMA. 265:1991;1545-1549.
25. Van Dorpe A., Piessens J., Willems J.L., De Geest H. Unexplained chest pain with normal coronary arteriograms. Cardiology. 74:1987;436-443.
26. Isner J.M., Salem D.N., Banas J.S., Levine H.J. Long-term clinical course of patients with normal coronary arteriography. follow-up study of 121 patients with normal or nearly normal coronary arteriograms Am Heart J. 102:1981;645-653.
27. Lavey E.B., Winkle R.A. Continuing disability of patients with chest pain and normal coronary arteriograms. J Chron Dis. 32:1979;191-196.
28. Okene I.S., Shay M.J., Alpert J.S., Weiner B.H., Dalen J.E. Unexplained chest pain in patients with normal coronary arteriograms. a follow-up study of functional status N Engl J Med. 303:1980;1249-1252.
29. Papanicolaou M.N., Califf R.M., Hiatky M.A.et al. Prognostic implications of angiographically normal and insignificantly narrowed coronary arteries. Am J Cardiol. 58:1986;1181-1187.
30. Pasremak R.C., Thibault G.E., Savoia M., De Sanctis R.W., Hutter A.M. Jr. Chest pain with angiographically insignificant coronary arterial obstruction. Am J Med. 68:1980;813-817.
31. Proudfit W.L., Bruschke A.V., Sones F.M. Clinical course of patients with normal or slightly or moderately abnormal coronary arteriograms. a 10-year follow-up of 521 patients Circulation. 62:1980;712-717.
32. Beitman B.D., Mukerji V., Russell J.L., Grafting M. Panic disorder in cardiology patients. a review of the Missouri panic/cardiology project J Psychiatric Res. 27(suppl 1):1993;35-46.
33. Fleet R.P., Dupuis G., Marchand A., Burelle D., Beitman B.D. Detecting panic disorder in emergency department chest pain patients. a validated model to improve recognition Ann Behav Med. 19:1997;124-131.
34. Fraenkel YM, Kindler S, Melmed RN. Differences in cognitions during chest pain in patients with panic disorder and ischemic heart disease. Depression Anxiety 1996/1997;4:217-222.
35. Barsky A.J., Ahern D.K., Delamater B.A., Clancy S.A., Bailey E.D. Differential diagnosis of palpitations. Preliminary development of a screening instrument. Arch Fam Med. 6:1997;241-245.
36. Ballenger J.C. Treatment of panic disorder in the general medical setting. J Psychosom Res. 44:1998;5-16.
37. Ballenger J.C. Comorbidity of panic and depression. implications for clinical management Int Clin Psychopharmacol. 13(suppl. 4):1998;13-17.
38. Sartorius N., Ustun T.B., Lecrubier Y., Wittchen H.U. Depression comorbid with anxiety. results from the WHO study on Psychological Disorders in Primary Health Care Br J Psychiatry. 168(suppl 30):1996;38-43.
39. Lecrubier Y., Usten T.B. Panic and depression. a worldwide primary care perspective Int Clin Psychopharmacol. 13(suppl. 4):1998;7-11.
40. Ormel J., Conkorff M., Ustun T.B.et al. Common mental health disorders and disability across cultures. JAMA. 272:1994;1741-1748.
41. Liebowitz M., Gorman J., Fyre A.et al. Lactate provocation of panic attacks. Arch Gen Psychiatry. 42:1985;709-719.
42. Fink M., Taylor M., Volavka J. Anxiety participated by lactate. N Engl J Med. 281:1970;1429-1436.
43. Bradwejn J., Kosztcki D., Annable L.et al. A dose ranging study of the behavioral and cardiovascular effects of CCK-tetrapeptide in panic disorder. Biol Psychiatry. 32:1992;903-912.
44. Barsky A., Cleary P., Sarnie M.et al. Panic disorders, palpitations and awareness of cardiac activities. J Nerv Ment Dis. 182:1994;63-71.
45. Stein M.B., Asmundson G.J.G. Autonomic function in panic disorder. cardiorespiratory and plasma catecholamine responsitivity to multiple challenges of the autonomic nervous system Biol Psychiatry. 36:1994;548-558.
46. Fraser F., Wilson R.M. The sympathetic nervous system and the "irritable heart" of soldiers. BMJ. 2:1918;27-29.
47. Wood P. DaCosta's syndrome (or effort syndrome). BMJ. 1:1941;805-811.
48. Friedman M. Studies concerning the etiology and pathogenesis of neurocirculatory asthenia. III. The cardiovascular manifestations of neurocirculatory asthenia. Am Heart J. 30:1945;478-491.
49. Breggin P.R. The psychophysiology of anxiety with a review of the literature concerning adrenaline. J Nerv Ment Dis. 139:1964;558-568.
50. Sartory G., Olajide D. Vagal innervation techniques in the treatment of panic disorder. Behav Res Ther. 26:1988;431-434.
51. Reiman E.M., Raichle M.E., Butler F.K.et al. A focal brain abnormality in panic disorder. a severe form of anxiety Nature. 310:1984;683-685.
52. Nordahl T.E., Semple W., Gross M.et al. Cerebral glucose metabolic differences in patients with panic disorder. Neuropsychopharmacology. 3:1990;261-272.
53. Levy M.N., Zieske H. Autonomic control of cardiac pacemaker activity and atrioventricular transmission. J Appl Physiol. 27:1969;465-470.
54. Levy M.N. Cardiac sympathetic-parasympathetic interactions. Fed Proc. 43:1984;2598-2602.
55. Friedman B.H., Thayer J.F., Borkovec T.D., Tyrrell R.A., Johnson B., Columbo P. Autonomic characteristics of nonclinical panic and blood phobia. Biol Psychiatry. 34:1993;298-310.
56. Miyawaki E., Salzman C. Autonomic nervous system tests in psychiatry. implications and potential uses for heart rate variability Integr Psychiatry. 7:1991;21-28.
57. Friedman B.H., Thayer J.F. Autonomic balance revisited. panic anxiety and heart rate variability J Psychosom Res. 44:1998;133-151.
58. Faravelli C., Marinoni M., Spiti R.et al. Abnormal brain hemodynamic responses during passive orthostatic challenge in panic disorder. Am J Psychiatry. 154:1997;378-383.
59. Kane F.J. Jr., Strohlein J., Harper R.G. Noncardiac chest pain in patients with heart disease. South Med J. 84:1991;847-852.
60. Rasmussen K., Funch-Jensen P., Ravnsbaek J. Esophageal spasm in patients with coronary artery disease. Lancet. i:1986;174-176.
61. Freeman L.J., Nixon P.G.F., Legg C. Hyperventilation and angina pectoris. J R Coll Phys Lond. 21:1986;46-50.
62. Martinez J.M., Coplan J.D., Browne S.T.et al. Hemodynamic response to respiratory challenges in panic disorder. J Psychosom Res. 44:1998;153-161.
63. Rosen S.D., Uren N.G., Kaski J.C.et al. Coronary vasodilator reserve, pain perception, and sex in patients with Syndiomex. Circ. 90:1994;50-60.
64. Lagerqvist B., Sylven C., Walderstrom A. Lower threshold for adenosine-induced chest pain in patients with angina and normal coronary angiograms. Br Heart J. 68:1992;282-285.
65. Pasceri V., Lanza G.A., Buffon A., Montenero A.S., Crea F., Maseri A. Role of abnormal pain sensitivity and behavioral factors in determining chest pain in syndrome X. J Am Coll Cardiol. 31:1998;62-66.
66. Fleet R.P., Dupuis G., Marchand A., Burelle D., Beitman B.D. Pain disorder, chest pain and coronary artery disease. literature review Can J Cardiol. 10:1994;827-834.
67. Cannon R.O., Quyyumi A.A., Mincemoyer R.et al. Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med. 330:1994;1411-1417.
68. Lebovits B., Shekelle R., Ostfeld A.et al. Prospective and retrospective studies of coronary heart disease. Psychosom Med. 29:1967;265-272.
69. Yingling K.W., Wulsin L.R., Arnold L.M., Rouan G.W. Estimated prevalences of panic disorder and depression among consecutive patients seen in the emergency department with acute chest pain. J Gen Intern Med. 8:1993;231-235.
70. Fleet R.P., Dupuis G., Marchand A.et al. Panic disorder in coronary artery disease patients with noncardiac chest pain. J Psychosom Res. 44:1998;81-90.
71. Ros E., Armengol X., Grande L.et al. Chest pain at rest in patients with coronary artery disease. myocardial ischemia, esophageal dysfunction, or panic disorder Dig Dis Sci. 42:1997;1344-1353.
72. Chernen L., Friedman S., Goldberg N., Feiyt A., Kwan T., Stein R. Cardiac disease and nonorganic chest pain. factors leading to disability Cardiology. 86:1995;15-21.
73. Weissman M.M., Klerman G.L., Markowitz J.S., Ouellette R. Suicidal ideation and suicide attempts in panic disorder and attacks. N Engl J Med. 321:1989;1209-1214.
74. Taylor C.B., King R., Ehlers A. Treadmill exercise test and ambulatory measures in panic attacks. Am J Cardiol. 60:1987;48J-52J.
75. Bajwa W.K., Asnis G.M., Sanderson W.C., Irfan A., Van Praag H.M. High cholesterol levels in patients with panic disorder. Am J Psychiatry. 149:1992;376-378.
76. Coryell W., Noyes R., Clancy J. Excess mortality in panic disorder. a comparison with primary unipolar depression Arch Gen Psychiatry. 39:1982;701-703.
77. Coryell W., Noyes R. Jr., House D.J. Mortality among outpatients with anxiety disorders. Am J Psychiatry. 143:1986;508-510.
78. Kawachi I., Colditz G.A., Ascherio A. Prospective study of phobic anxiety and risk of coronary artery disease in men. Circulation. 89:1994;1992-1997.
79. Kawachi I., Colditz G.A., Ascherio A.et al. Prospective study of phobic anxiety and risk of coronary heart disease in men. Circulation. 89:1994;1992-1997.
80. Kawachi I., Sparrow D., Vokonas P.S., Weiss S.T. Decreased heart rate variability in men with phobic anxiety (data from the Normative Aging Study). Am J Cardiol. 75:1995;882-885.
81. Kemp H.G., Kronmal R.A., Vlietstra R.E., Frye R.L. Seven year survival of patients with normal or near normal coronary arteriograms. a CASS registry study J Am Coll Cardiol. 7:1986;479-483.
82. Barsky A.J., Cleary P.D., Coeytaux R.R., Ruskin J.N. The clinical course of palpitations in medical outpatients. Arch Intern Med. 155:1995;1782-1788.
83. Veitman B., Bacha I., Trombka L.et al. Pharmacotherapeutic treatment of panic disorder in patients presenting with chest pain. J Fam Pract. 28:1989;177-180.
84. Zaubler T.S., Katon W. Panic disorder and medical comorbidity. a review of the medical and psychiatric literature Bull Menninger Clin. 60(suppl A):1996;A12-A38.
85. Kahn J.P., Drusin R.E., Klein D.F. Idiopathic cardiomyopathy and panic disorder. clinical association in cardiac transplant candidates Am J Psychiatry. 144:1987;1327-1330.
86. Kahn J.P., Gorman J.M., King D.L., Fyer A.J., Liebowitz M.R., Klein D.F. Cardiac left ventricular hypertrophy and chamber dilatation in panic disorder patients. implications for idiopathic dilated cardiomyopathy Psychiatry Res. 32:1990;55-61.
87. Alpert M.A., Mukerji V., Sabeti M., Russell J.L., Beitman B.D. Mitral valve prolapse, panic disorder and chest pain. Med Clin N Am. 75:1991;1119-1133.
88. Margraff J., Ehlers A., Roth W.T. Mitral valve prolapse and panic disorder. a review of their relationship Psychosom Med. 50:1988;93-113.
89. Yang S., Tsai T.H., Hou Z.Y., Chen C.Y., Sim C.B. The effect of panic attack on mitral valve prolapse. Acta Psychiatrica Scand. 96:1997;408-411.
90. Dan D., Gubb B., Mouhaffel A., Kosinski D.J. Use of serotonin re-uptake inhibitors as primary therapy for carotid sinus hypersensitivity. Pacing Clin Electrophysiol. 20:1997;1633-1635.
91. Beitman B.D., Mukerji V., Alpert M., Peters J.C. Panic disorder in cardiology patients. Psychiatric Med. 8:1990;67-81.
92. Kapoor W.N. Evaluation and management of the patient with syncope. JAMA. 268:1992;2553-2560.
93. Krahn A.D., Yee R., Klein G.J., Morillo C. Inappropriate sinus tachycardia. evaluation and therapy J Cardiovasc Electrophysiol. 6:1995;1124-1128.
94. Sartorius N, Ustun TB, Costa e Silva JA, et al. An international study of psychological problems in primary care: preliminary report from the World Health Organization Collaborative Project on "Psychological Problems in General Health Care." 1993;50:819-824.
95. Katerndahl D.A., Trammell C. Prevalence and recognition of panic states in STARNET patients presenting with chest pain. J Fam Pract. 45:1997;54-63.
96. Katon W.J., Von Korff M., Lin E. Panic disorder. relationship to high medical utilization Am J Med. 92(suppl 1A):1992;7S-11S.
97. Clum G.A., Surls A meta-analysis of treatments for panic disorder. J Consult Clin Psychol. 61:1993;317-326.
98. Margraf J., Barlow D.H., Clark D.M., Telch M.J. Psychological treatment for panic. work in progress on outcome, active ingredients, and follow-up Behav Res Ther. 31:1993;1-8.
99. Practice guidelines for the treatment of patients with panic disorder. Work group on panic disorder. American Psychiatric Association. Am J Psychiatry 1998;155(suppl 5):1-34.
100. Barlow D.H. Cognitive-behavioral therapy for panic disorder. current status J Clin Psychiatry. 58(suppl 2):1997;32-36.
101. Klein D., Fink M. Psychiatric reaction patterns to imipramine. Am J Psychiatry. 199:1962;432-438.
102. Schweizer E., Rickels K., Weiss S.et al. Maintenance drug treatment of panic disorder. results of a prospective, placebo-controlled comparison of alprazolam and imipramine Arch Gen Psychiatry. 50:1993;51-60.
103. Andersch S., Rosenberg N.K., Kullingsjo H.et al. Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. a Scandinavian multicenter study Acta Psychiatrica Scand. 365:1991;18-27.
104. Zley R., Kahn R., McNair D.et al. A comparison of alprazolam and imipramine in the treatment of agoraphobia and panic disorder. Psychopharmacol Bull. 22:1986;167-172.
105. Ballenger J., Burrows G., DuPont R.et al. Alprazolam in panic disorder and agoraphobia; results from a multicentre trial. Arch Gen Psychiatry. 5:1988;413-422.
106. Chouinard G., Annabele L., Fontaine R.et al. Alprazolam in the treatment of generalized anxiety in panic disorder. a double-blind, placebo controlled study Psychopharmacology. 77:1982;229-233.
107. Uhlenuth E., Matuzas W., Glass R.et al. Response of panic disorder to fixed doses of alprazolam or imipramine. J Affect Disord. 17:1989;261-270.
108. Lesser I., Lydiard R., Endral E.et al. Alprazolam plasma concentrations and treatment response in panic and agoraphobia. Am J Psychiatry. 149:1992;1556-1562.
109. Lydiard R., Lesser I., Ballenger J.et al. A fixed-dose study of alprazolam 2 mg, alprazolam 6 mg, and placebo in panic disorder. J Clin Psychopharmacol. 12:1992;96-103.
110. Tesar G., Rosenbaum J., Pollack M.et al. A double-bind, placebo controlled comparison of clonazepam and alprazolam for panic disorder. J Clin Psychiatry. 52:1991;69-76.
111. Tesar G., Rosenbaum J. Successful use of clonazepam in patients with treatment-resistant panic disorder. J Nerv Ment Dis. 164:1986;477-482.
112. Roy-Byrne P.P. Integrated treatment of panic disorder. Am J Med. 92(suppl 1A):1992;49S-54S.
113. Louie A.K., Lewis T.B., Lannon R.A. Use of low-dose fluoxetine in major depression and panic disorder. J Clin Psychiatry. 54:1993;435-438.
114. Beitman B.D., Basha I., Trombka L.H.et al. Pharmacotherapeutic treatment of panic disorder in patients presenting with chest pain. J Fam Pract. 28:1989;177-180.
115. Mendels J., Chernoff R.W., Blatt M. Alprazolam as adjunct to propranolol in anxious patients with stable angina pectoris. J Clin Psychiatry. 47:1986;8-11.
116. Taylor C.B., Hayward C., King B.et al. Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder. results of a double blind placebo trial J Clin Psychopharmacol. 10:1990;112-118.
117. Oehrberg P.E., Christiansen K., Behnke A.L.et al. Paroxetine in the treatment of panic disorder. a randomized double-blind, placebo-controlled study Br J Psychiatry. 167:1995;374-379.
118. Lecrubier Y., Bakker A., Dunbar G.et al. A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Acta Psychiatrica Scand. 95:1997;145-152.
119. Lecrubier Y., Judge R., the Collaborative Paroxetine Panic Study investigators Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Acta Psychiatrica Scand. 95:1997;153-160.
120. Ballenger J.C., Wheadon D.E., Steiner M.et al. Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder. Am J Psychiatry. 155:1998;36-42.
121. Black D.W., Wesner R., Bowers W.et al. A comparison of fluovoxamine, cognitive therapy and placebo in the treatment of panic disorder. Arch Gen Psychiatry. 50:1993;44-50.
122. Sheehan D.V. Current concepts in the treatment of panic disorder. Journal of Clinical Psychiatry. 60(suppl. 18):1999;16-21.
123. Jefferson J.W. Antidepressants in panic disorder. J Clin Psychiatry. 58(suppl 2):1997;20-24.
124. Boyer W. Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks. a meta-analysis Int Clin Psychopharmacol. 10:1995;45-49.
125. Ballenger J.C. Selective serotonin re-uptake inhibitors in panic disorder. Feighner J.P., Boyer W.F. Selective serotonin re-uptake inhibitors. 2nd ed:1996;155-178 John Wiley & Sons, West Sussex, UK.
126. Shorter E. From paralysis to fatigue. a history of psychosomatic medicine in the modern era:1992;Free Press, New York.
127. Noyes R., Kathol R., Clancy J.et al. Antianxiety effects of propranolol. a review of clinical studies Klein D.F., Rabkin J. Anxiety. new research and changing concepts:1981;Raven Press, New York.
128. Granville-Grossman K.L., Turner P. The effect of propranolol on anxiety. Lancet. i:1966;788-790.
129. Pohl R., Yeragani V., Balon R., Ortiz A., Aleem A. Isoproterenol-induced panic. a beta-adrenergic model of panic anxiety Ballenger J.C. Neurobiology of panic disorder. 1990;107-120 Wiley-Liss, New York.
130. Kellner R., Collins A.C., Shurman R.S.et al. The short term antianxiety effects of propranolol HCL. J Clin Pharmacol. 14:1974;301-304.
131. Rosano G.M.C., Peters N.S., Lefroy D.et al. 17-beta-estradiol therapy lessens angina in postmenopausal women with syndrome X. J Am Coll Cardiol. 28:1996;1500-1505.